Thank you to everyone who came out to Cancer in the Crosshairs lead by professors Shaheen Sikandar and Laura Sanchez, and research scientist Melissa Cline! Looking forward to learning more about their incredible research fighting against breast and ovarian cancer 🔬
UC Santa Cruz Genomics Institute’s Post
More Relevant Posts
-
Attending #aacr2024? Stop by and visit my poster, Abstract 5494: Spatial organization between claudin and the tumor microenvironment in head and neck squamous cell carcinomas Presentation: April 9, 2024, 1:30 p.m. – 5:00 p.m. | Section 10 | Poster Board #16 We'll be highlighting utility of our own end to end spatial solution, MultiOmyx together with #nanostring IO360 gene expression for a comprehensive analysis of the TME of squamous cell carcinomas.
NeoGenomics is thrilled to be sharing posters at the American Association for Cancer Research® (AACR) Annual Meeting 2024. We’re proud to showcase our research in precision medicine, cancer testing, and more. To browse titles, authors and presentation details, please visit: https://lnkd.in/gE4zhhvG
To view or add a comment, sign in
-
Did you participate in the Cancer Discovery Virtual Symposium on Reducing the Global Burden in September? During the symposium, a global cancer research panel including Satish Gopal, Bob Li, Isabel Mestres, CS Pramesh, and Eric Solary, discussed how international efforts to understand and combat cancer can be integrated for maximum worldwide impact while not overlooking the unique challenges different regions face. Watch it now on demand to be inspired by their stories: https://bit.ly/3Onv0cc
To view or add a comment, sign in
-
Last week I attended this Innovation Series Seminar! I am really happy for what NUNO Prego Ramos has achieved! Also, this success story is an inspiration for biotech projects from Portugal! The quality of the content was huge, but I will highlight: 1) Aim for something bigger than ourselves; 2) Negative experiences give you lessons to learn; 3) Manage people with transparency. I would say that the key to success is take care of your relationships! #entrepreneurship #innovation #technologytransfer
💡 The first open session of the Innovation Speaker Series with guest speaker NUNO Prego Ramos is this Wednesday, 29 May - Join us! Our guest will share the journey of CellmAbs, from its early days starting with an initial technology from NOVA University to becoming a pioneering force in cancer therapy innovation 🙌 The Innovation Speaker Series was originally designed to introduce the Champalimaud Foundation’s Community on how to bring their research to the marketplace, but this session is open to all. 🎙️ NUNO Prego Ramos, Co-Founder and CEO of CellmAbs 📅 29 May 24 🕒 3pm 📍 Seminar Room, Champalimaud Foundation 🎟️ Free event, but RSVP is required: https://lnkd.in/daEYBGwS #InnovationSpeakerSeries #FreeEvent #BiotechInnovation Nina Patrick, PhD
To view or add a comment, sign in
-
At CSB+SJU, students like Tom VanDenEinde are using their skills to create real-world impact. Learn more about Tom's summer research project and how it could revolutionize breast cancer detection: https://lnkd.in/gGKMp5Ty
SJU senior working on new way to detect breast cancer
To view or add a comment, sign in
-
📑 You can read the entire manuscript here: https://lnkd.in/ddrnVeKQ Stay informed and empowered in the battle against #EndometrialCancer #CancerResearch #MedicalScience #Diagnostics
I'm glad to announce, that we recently published an article in Diagnostics MDPI, referring to immunohistochemical assessment of receptors in endometrial cancer. 🔬 Thanks and congrats to Stanisław Przewoźny and colleagues from Department of Immunobiology PUMS!
To view or add a comment, sign in
-
Pancreas Cancer 2024: Translating Genomic Findings into Clinical Actionability— Eileen M. O’Reilly will address this topic in a keynote lecture at the AACR Special Conference on Advances in Pancreatic Cancer Research (September 15-18, Boston). Learn more: https://bit.ly/4fcTjW4 #AACRpan24
To view or add a comment, sign in
-
❇️ NEOPRISM-CRC is the first multicenter, phase 2 trial to determine the safety and efficacy of neoadjuvant #pembrolizumab when stratified by TMB for high-risk stage II-III #colorectal cancer. ❇️ Learn about the new study data presented at #ASCO24 by Dr. Kai-Keen Shiu of UCL Cancer Institute:
To view or add a comment, sign in
-
🧪 Dr. Suneel Kamath discusses exciting data from the CodeBreaK 300 trial along with Drs. Arvind Dasari and Sakti Chakrabarti. 📺 The panel also discusses the use of ctDNA in adjuvant settings and sequencing challenges in #colorectal cancer: https://buff.ly/46bFuDi
To view or add a comment, sign in
-
👩🏫 I find this article truly amazing! 🌟 In this review paper, the therapeutic potencies of curcumin for breast cancer are comprehensively represented through explaining the mechanisms by which this interesting flavonoid performs its cancer-fighting activity and having a great insight on various nano-delivery systems, utilized for a better targeted therapy 👩💻. The link to access is: https://lnkd.in/gP3q-Z2B
To view or add a comment, sign in
-
The goal of this workshop is to discuss common and specific mouse models of cancer cachexia, and the methodology underlying their use and endpoints. With enormous thanks to Endevica Bio, Almac Discovery and the Cancer Cachexia Society for sponsoring, and UCSD for hosting.
To view or add a comment, sign in
3,232 followers
Leadership Giving Officer at University of California, Santa Cruz
2moIt was really well put together and the speakers were amazing.